These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 35659923)
1. Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism. Li H; Dai H; Li J J Adv Res; 2023 Mar; 45():15-29. PubMed ID: 35659923 [TBL] [Abstract][Full Text] [Related]
7. Musculoskeletal Progenitor/Stromal Cell-Derived Mitochondria Modulate Cell Differentiation and Therapeutical Function. Jorgensen C; Khoury M Front Immunol; 2021; 12():606781. PubMed ID: 33763061 [TBL] [Abstract][Full Text] [Related]
8. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases. Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107 [TBL] [Abstract][Full Text] [Related]
9. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients. Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608 [TBL] [Abstract][Full Text] [Related]
10. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors. Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG Front Immunol; 2020; 11():54. PubMed ID: 32117234 [TBL] [Abstract][Full Text] [Related]
11. The immunomodulation-immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility. Cequier A; Vázquez FJ; Romero A; Vitoria A; Bernad E; García-Martínez M; Gascón I; Barrachina L; Rodellar C Front Vet Sci; 2022; 9():957153. PubMed ID: 36337202 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications. Huang Y; Wu Q; Tam PKH Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cell based therapies for the treatment of immune disorders: recent milestones and future challenges. Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM Expert Opin Drug Deliv; 2020 Feb; 17(2):189-200. PubMed ID: 31918562 [No Abstract] [Full Text] [Related]
14. Dose and duration of interferon γ pre-licensing interact with donor characteristics to influence the expression and function of indoleamine-2,3-dioxygenase in mesenchymal stromal cells. Boyt DT; Boland LK; Burand AJ; Brown AJ; Ankrum JA J R Soc Interface; 2020 Jun; 17(167):20190815. PubMed ID: 32546114 [TBL] [Abstract][Full Text] [Related]
15. Key Metabolic Pathways in MSC-Mediated Immunomodulation: Implications for the Prophylaxis and Treatment of Graft Versus Host Disease. Burnham AJ; Foppiani EM; Horwitz EM Front Immunol; 2020; 11():609277. PubMed ID: 33365034 [TBL] [Abstract][Full Text] [Related]
16. IDO and CD40 May Be Key Molecules for Immunomodulatory Capacity of the Primed Tonsil-Derived Mesenchymal Stem Cells. Lee HJ; Jung H; Kim DK Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071285 [No Abstract] [Full Text] [Related]
17. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells. Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Song N; Scholtemeijer M; Shah K Trends Pharmacol Sci; 2020 Sep; 41(9):653-664. PubMed ID: 32709406 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs. Weiss ARR; Dahlke MH Front Immunol; 2019; 10():1191. PubMed ID: 31214172 [TBL] [Abstract][Full Text] [Related]
20. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential. Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Gosálvez J; Roy R; Zaragoza P; Martín-Burriel I; Rodellar C Stem Cells Dev; 2017 Jan; 26(1):15-24. PubMed ID: 27712399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]